Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FRMD4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NUP210 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADSS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNRPE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL38 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFATC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WNT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRP12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSTR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADRA1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on